Press release today: latest press releases

Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing

ORION CORPORATION PRESS RELEASE 05 OCTOBER 2026 at 8:00am ET Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing Milestone

October 21, 2026

Business·Press Release

Iceland Seafood International hf: 1H 2026 results and investors presentation

Strong First-Half Performance with Sales up 16.7% as profit after tax doubled in 1H 2026 Sales for 1H 2026: €273.0m, up 16.7% from 1H 2025 Net margin for 1H 2026: €23.7m, up

October 21, 2026

Business·Press Release

Siguldas CMAS JSC Audited Annual Report for 2022

The Company’s net turnover in 2022 was 1.6 million euros, which is by 168 thousand euros or 12.1% bigger than in 2021. The proportion of the revenue from the Company’s basic economic

October 21, 2026

Business·Press Release

Equinor ASA: Buy-back of shares to share programmes for employees

Please see below information about transactions made under the buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR) for shares to be used in the share-based incentive programmes for employees and management. Date on

October 21, 2026

Business·Press Release

CoinShares XBT Provider AB (publ) – 2017 Issuance Programme Change of FX Source/FX Rate

CoinShares XBT Provider AB (publ)LEI: 549300HGWKR2Q5T8GK64 3 September 2026 CoinShares XBT Provider AB (publ) Issuance Programme for the issue of Bitcoin Tracker Certificates and Ethereum Tracker Certificates Change of FX Rate/FX Source

October 21, 2026

Business·Press Release

Xali Gold Completes FTA Application for Drilling and Outlines Development Team for Pico Machay

VANCOUVER, British Columbia, Oct. 21, 2026 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that it has completed its Ficha Técnica Ambiental (“FTA”) application

October 21, 2026

Business·Press Release

LHV Group’s own share acquisition transactions

AS LHV Group announces that during the period 11 September to 17 September 2026, it has acquired the company’s own shares on the Nasdaq Tallinn Stock Exchange as follows: Date Aggregated volume (pcs) Weighted average price

October 21, 2026

Business·Press Release

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

ORION CORPORATION PRESS RELEASE 6 OCTOBER 2026 at 9.00 EEST Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market Orion Corporation (“Orion Pharma”) and Qilu Pharma Europe

October 21, 2026

Business·Press Release

Siguldas CMAS JSC Notice to the Regular Shareholders’ Meeting on 21 April 2023

The Management Board of Joint Stock Company ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ (unified reg. No. 40003013295, legal address: ‘Kalnabeites 8’, Sigulda, Sigulda area, LV-2150) announces that regular shareholders’ meeting of the

October 21, 2026

Business·Press Release

Notice on Convening an Extraordinary General Meeting of Shareholders of EPSO-G

In accordance with the initiative and decision of the Board of New Energy Group EPSO-G (legal entity code 302826889, registered address Laisvės pr. 10, Vilnius, Lithuania) the Extraordinary General Meeting of EPSO-G

October 21, 2026

Business·Press Release

Press Release- Page 53

Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing

Iceland Seafood International hf: 1H 2026 results and investors presentation

Siguldas CMAS JSC Audited Annual Report for 2022

Equinor ASA: Buy-back of shares to share programmes for employees

CoinShares XBT Provider AB (publ) – 2017 Issuance Programme Change of FX Source/FX Rate

Xali Gold Completes FTA Application for Drilling and Outlines Development Team for Pico Machay

LHV Group’s own share acquisition transactions

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Siguldas CMAS JSC Notice to the Regular Shareholders’ Meeting on 21 April 2023

Notice on Convening an Extraordinary General Meeting of Shareholders of EPSO-G

Radical Islam is being appreciated by Indian authorities too

Bangladesh; India’s Biggest Ally or China’s Dragon Nest?

Ahmadis in Bangladesh face fresh threat of persecution

Latest Posts

France Reports 1,314 Arrests After Protests Over Schools and Living Costs

Trump heads to Michigan after Obama rallies Democrats

Pat McAfee Got Bradley Cooper’s Coaching for ‘The Mosquito Bowl’

Debris Injures Two in Southern Saudi Arabia After Houthi Missile Interceptions

Press Release- Page 53

Follow

Latest Posts